Illumina, Inc. (ILMN)
262.54
-5.39
(-2.01%)
USD |
NASDAQ |
Oct 16, 16:00
260.01
-2.53
(-0.96%)
After-Hours: 20:00
Illumina Cash from Investing (Quarterly) : -122.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.00M |
| March 31, 2026 | -366.00M |
| December 31, 2025 | 108.00M |
| September 30, 2025 | -51.00M |
| June 30, 2025 | -49.00M |
| March 31, 2025 | -63.00M |
| December 31, 2024 | -48.00M |
| September 30, 2024 | -41.00M |
| June 30, 2024 | -41.00M |
| March 31, 2024 | -48.00M |
| December 31, 2023 | -85.00M |
| September 30, 2023 | -53.00M |
| June 30, 2023 | -37.00M |
| March 31, 2023 | -56.00M |
| December 31, 2022 | -102.00M |
| September 30, 2022 | -250.00M |
| June 30, 2022 | -165.00M |
| March 31, 2022 | -74.00M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -2.448B |
| June 30, 2021 | 3.00M |
| March 31, 2021 | 1.376B |
| December 31, 2020 | -34.00M |
| September 30, 2020 | -65.00M |
| June 30, 2020 | -320.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -135.00M |
| December 31, 2019 | -104.00M |
| September 30, 2019 | -218.00M |
| June 30, 2019 | 79.00M |
| March 31, 2019 | 988.00M |
| December 31, 2018 | -348.00M |
| September 30, 2018 | -940.00M |
| June 30, 2018 | -506.00M |
| March 31, 2018 | 73.00M |
| December 31, 2017 | -315.00M |
| September 30, 2017 | -54.00M |
| June 30, 2017 | 55.00M |
| March 31, 2017 | 179.00M |
| December 31, 2016 | -164.29M |
| September 30, 2016 | -341.23M |
| June 30, 2016 | 43.54M |
| March 31, 2016 | 36.45M |
| December 31, 2015 | 229.40M |
| September 30, 2015 | -6.799M |
| June 30, 2015 | -142.47M |
| March 31, 2015 | -154.15M |
| December 31, 2014 | -332.78M |
| September 30, 2014 | -44.23M |
| June 30, 2014 | 114.78M |
| March 31, 2014 | -144.39M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 164.00M |
| Agilent Technologies, Inc. | -1.032B |
| Pacific Biosciences of California, Inc. | 40.07M |
| Danaher Corp. | -10.15B |
| Bio-Rad Laboratories, Inc. | -66.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 201.00M |
| Cash from Financing (Quarterly) | -129.00M |
| Free Cash Flow | 511.00M |
| Free Cash Flow Per Share (Quarterly) | 1.039 |
| Free Cash Flow to Equity (Quarterly) | 176.00M |
| Free Cash Flow to Firm (Quarterly) | 178.11M |
| Free Cash Flow Yield | 1.27% |